Trazodone is an anti-depressant which acts as a serotonin antagonist reuptake inhibitor making it part of the SARI class of anti-depressants, a relatively less prescribed class compared to SSRI's such as Prozac. As well as its anti-depressant effects, Trazodone also exhibits both anxiolytic and hypnotic effects that has sometimes seen this prescribed for anxiety or to help induce sleep. Its toxicity and side effects are very different in scope compared to traditional SSRI class anti-depressants. Its major use case is in the treatment of unipolar depression, anxiety and insomnia.
Trazodone has been used off-label for a wide variety of conditions including but not limited to fibromyalgia, schizophrenia, diabetic neuropathy and panic disorder.
Trazodone has relatively mild side effects and similar efficacy in treating major depression as drugs such as amitriptyline and its anxiolytic properties and low cardiotoxicity are two benefits of using Trazodone while its lack of action on cholinergic pathways has made it popular for treating elderly patients suffering from depression.
Trazodone has been utilised for many years with a diverse range of individuals of all ages and sexes.
Trazodone dosing and length of administration very much depends on the assessment of a medical professional, but there are many individuals who have used Trazodone for many years and lived a more contented life. Always refer to product literature